Genetic characterization of diphtheria tox B to evaluate vaccine efficacy in Indonesia
,
Abstract
Background and Objectives: Blocking the attachment of diphtheria toxins to host cells through the intact receptor binding site (tox B) was the initial mechanism of action of the diphtheria vaccine. Diphtheria outbreaks in populations with good vaccination coverage can be caused by mutations or changes in the genetic structure of the tox B protein. The aim of this study was to characterize the Tox B protein produced by Corynebacterium diphtheriae isolated from 2018 to 2019 in patients in Jakarta who had already received the diphtheria vaccine.
Materials and Methods: Of the 89 throat swab specimens of patients with a clinical diagnosis of diphtheria, 10 were positive for diphtheria and toxin. PCR was used to amplify the tox B DNA fragment in the 10 positive isolates. DNA sequencing was conducted with overlapping primers and the DNA sequences were analysed by using SeqScape V2.7.
Results: Of the 10 isolates, nine isolate showed a DNA mutation (G30A), but the mutation did not change the amino acid encoding arginin (silent mutation). Our findings indicate that the efficacy of the diphtheria vaccine used in Indonesia has not decreased because of mutations in the tox B genes not change the amino acid.
Conclusion: Overall, there are no amino acid changes in the tox B protein, indicating that the outbreaks are not affected by mutation in tox B. Another possible mechanism – overexpression of the toxin – is likely responsible for causing diphtheria in patients who have a complete history of immunization in Indonesia.
2. Zajdowicz SLW, Holmes RK (2016). Phage Conversion and the Role of Bacteriophage and Host Functions in Regulation of Diphtheria Toxin Production by Corynebacterium diphtheriae. In: The Mechanistic Benefits of Microbial Symbionts, Advances in Environmental Microbiology. Springer International Publishing, Switzerland. pp. 15-45.
3. De Zoysa A, Efstratiou A, Mann G, Harrison TG, Fry NK. Development, validation and implementation of a quadriplex real-time PCR assay for identification of potentially toxigenic corynebacteria. J Med Microbiol 2016; 65: 1521-1527.
4. Riedel S, Morse SA, Mietzner TA, Miller S, Hobden JA, Detrick B, et al (2019). Corynebacterium diphtheriae (Aerobic Non Spore Forming Gram Positive Bacilli: Corynebacterium, Listeria, Erysipelothrix). In: Medical Microbiology. Ed, Jawetz, Melnick, Adelbergs. McGraw Hill Professional, 28th ed. USA, pp.196-199.
5. Talaro KP, Chess B (2008). Foundation in Microbiology. McGraw-Hill Companies. New York, USA.
6. Beh P, Byard R W. Diphtheria and lethal upper airway obstruction. Forensic Sci Med Pathol 2015; 11: 133-135.
7. World Health Organization. Diphtheria vaccine: WHO position paper, August 2017 – Recommendations. Vaccine 2018; 36: 199-201.
8. Tosepu R, Gunawan J, Effendy DS, Ahmad LOAI, Farzan A. The outbreak of diphtheria in Indonesia. Pan Afr Med J 2018; 31: 249.
9. Husada D, Primayani D, Marbun K, Kartina L, Puspitasari D, Tirthaningsih N, et al. Risk factors of diphtheria carriers in Indonesian children. Southeast Asian J Trop Med Public Health 2018; 49: 660-669.
10. Hughes GJ, Mikhail AFW, Husada D, Irawan E, Kafatos G, Bracebridge S, et al. Seroprevalence and determinants of immunity to diphtheria for children living in two districts of contrasting incidence in East Java, Indonesia. Pediatr Infect Dis J 2015; 34: 1152-1156.
11. Swart EM, Van Gageldonk PGM, De Melker HE, Van Der Klis FR, Berbers GAM, Mollema L. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study. PLoS One 2016; 11(2): e0148605.
12. Kitamura N, Le TTT, Le LT, Nguyen LD, Dao AT, Hoang TT, et al. Diphtheria Outbreaks in Schools in Central Highland Districts, Vietnam, 2015–2018. Emerg Infect Dis 2020; 26: 596-600.
13. Abulmagd S, Emara M, Aziz S, El- Domany R. Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine. Indian J Med Microbiol 2013; 31: 3-9.
14. Le TV, Nguyen VTT, Nguyen QH, Nguyen TTT, Duong TTN, Ly TTT, et al. The evaluation of anti-diphtheria toxoid antibodies in healthy population in Kon Tum, Vietnam: a population-based study. IJID Reg 2022; 3: 171-176.
15. Abdul A, Lichtman A, Pillai S (2012). Cellular and molecular immunology. Elsevier Health Sciences, 7th ed. Philadelphia, USA.
16. Kolodkina VL, Titov LP, Sharapa TN, Drozhzhina ON. Point mutations in tox promoter/operator and diphtheria toxin repressor (dtxR) gene associated with the level of toxin production by Corynebacterium diphtheriae strains isolated in Belarus. Mol Gen Mikrobiol Virusol 2007; (1): 22-29.
17. Doyle CJ, Mazins A, Graham RMA, Fang N-X, Smith HV, Jennison AV. Sequence analysis of toxin gene–bearing Corynebacterium diphtheriae strains, Australia. Emerg Infect Dis 2017; 23: 105-107.
18. Holmes RK. Biology and Molecular Epidemiology of Diphtheria Toxin and the tox Gene. J Infect Dis 2000; 181 Suppl 1: S156-167.
19. Mokrousov I. Corynebacterium diphtheriae: genome diversity, population structure and genotyping perspectives. Infect Genet Evol 2009; 9: 1-15.
20. Kunkle CA, Schmitt MP. Analysis of a DtxR-regulated iron transport and siderophore biosynthesis gene cluster in Corynebacterium diphtheriae. J Bacteriol 2005; 187: 422-433.
| Files | ||
| Issue | Vol 14 No 4 (2022) | |
| Section | Short Communication | |
| DOI | https://doi.org/10.18502/ijm.v14i4.10248 | |
| Keywords | ||
| Diphteria; Genetic characterization; Indonesia; Mutation; Tox B | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
